pharmacopeia

Pulmonary Hypertension

9 drugs4,713 FAERS reportsMedDRA PT
GET
/api/v1/reaction/pulmonary-hypertension
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.

DefinitionNLM MeSH D006976

Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.

Source: U.S. National Library of Medicine — MeSH (Hypertension, Pulmonary)

Drugs reporting Pulmonary Hypertension (9)

Share = reports listing this reaction ÷ total matched reports for the drug. means the upstream totals query failed at ingest and the denominator is unknown.

  1. 1Aficamten120%
  2. 2Iloprost404.5%
  3. 3Isocarboxazid34.2%
  4. 4Nitric Oxide1393.2%
  5. 5Chlorothiazide372.9%
  6. 6Poractant Alfa192.7%
  7. 7Sildenafil2,9892.4%
  8. 8Diazoxide222.1%
  9. 9Bosentan1,463

Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.

Literature

Recent PubMed references pinned to Hypertension, Pulmonary as a MeSH major topic. About the reaction term itself — not about any specific drug.

Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.

Search pharmacopeia

Search drugs, classes, and ingredients